Uncategorized
Phase 2 Clinical Trial of Retinitis Pigmentosa Treatment Completed
R-Tech Ueno Ltd. (Tokyo, Japan) announced it has
completed a phase 2 clinical trial of 0.15% UF-021 isopropyl
unoprostone (Ocuseva), which is under development
as a treatment for retinitis pigmentosa. The
trial investigated the possibility of improving visual
function in the central part of the retina with UF-021 in pa...